Kanagaraju Ponnusamy

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia.

Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia.

Journal: Blood
Published: March 21, 2025

MAF functions as a pioneer transcription factor that initiates and sustains myelomagenesis.

MAF functions as a pioneer transcription factor that initiates and sustains myelomagenesis.

Journal: Blood advances
Published: January 17, 2023

CAR-iNKT cells targeting clonal TCRVβ chains as a precise strategy to treat T cell lymphoma.

CAR-iNKT cells targeting clonal TCRVβ chains as a precise strategy to treat T cell lymphoma.

Journal: Frontiers in immunology
Published: December 07, 2022

Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myeloma.

Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myeloma.

Journal: Blood
Published: October 12, 2021

Single-cell profiling of human bone marrow progenitors reveals mechanisms of failing erythropoiesis in Diamond-Blackfan anemia.

Single-cell profiling of human bone marrow progenitors reveals mechanisms of failing erythropoiesis in Diamond-Blackfan anemia.

Journal: Science translational medicine
Published: September 13, 2021

Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in Myelofibrosis.

Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in Myelofibrosis.

Journal: Cancers
Published: August 30, 2021

The innate sensor ZBP1-IRF3 axis regulates cell proliferation in multiple myeloma.

The innate sensor ZBP1-IRF3 axis regulates cell proliferation in multiple myeloma.

Journal: Haematologica
Published: October 20, 2020

Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma.

Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma.

Journal: Nature communications
Published: October 05, 2020

Brd2/4 and Myc regulate alternative cell lineage programmes during early osteoclast differentiation in vitro.

Brd2/4 and Myc regulate alternative cell lineage programmes during early osteoclast differentiation in vitro.

Journal: iScience
Published: October 02, 2020

Myeloma Propagating Cells, Drug Resistance and Relapse.

Myeloma Propagating Cells, Drug Resistance and Relapse.

Journal: Stem cells (Dayton, Ohio)
Published: May 12, 2015

RUNX1/ETO blocks selectin-mediated adhesion via epigenetic silencing of PSGL-1.

RUNX1/ETO blocks selectin-mediated adhesion via epigenetic silencing of PSGL-1.

Journal: Oncogenesis
Published: November 24, 2014

The truncated RUNX1/ETO activates VLA-4-dependent adhesion and migration of hematopoietic progenitor cells.

The truncated RUNX1/ETO activates VLA-4-dependent adhesion and migration of hematopoietic progenitor cells.

Journal: Haematologica
Published: August 10, 2014
Showing 1-12 of 14

Last Updated: 09/26/2026